EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Lineage Plasticity and Histologic Transformation in EGFR-TKI Resistant Lung Cancer

Li Yieng Eunice Lau iD, Anders Jacobsen Skanderup, Aaron C Tan iD

International Journal of Molecular Sciences · 31.12.2025 · 27 (1) · 445

DOI: 10.3390/ijms27010445 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 31.12.2025. Verfasst von Li Yieng Eunice Lau und 2 weiteren Autor:innen. Beteiligte Einrichtung: Genome Institute of Singapore (GIS), Agency for Science, Technology and Research (A*STAR), 60 Biopolis Street, Genome, Singapore 138672, Singapore. Hauptthemen laut MEDLINE: Lung Neoplasms, Drug Resistance, Neoplasm, Protein Kinase Inhibitors, Cell Transformation, Neoplastic. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 79 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Lineage plasticity, the ability of cancer cells to alter their differentiated state through transcriptional and epigenetic reprogramming, has emerged as a key mechanism of therapeutic resistance across cancers. This adaptive process can manifest in multiple ways, including epithelial–mesenchymal transition, acquisition of stem-like features, and histological transformation, the most striking and clinically apparent example. In EGFR-mutant lung adenocarcinoma (LUAD), lineage plasticity is increasingly recognized as a prevalent mechanism of acquired resistance to tyrosine kinase inhibitors (TKIs). Among its visible manifestations, histologic transformation into small-cell lung cancer (SCLC) is the most frequent, while squamous transformation and other phenotypic shifts also occur. Transformed tumors typically retain the initiating EGFR mutation but lose EGFR dependence, acquire neuroendocrine features, and display aggressive clinical behavior with poor clinical outcomes compared with both de novo SCLC and non-transformed LUAD. Recent studies show that plasticity arises through combined genomic, transcriptomic, and epigenetic reprogramming, often foreshadowed by molecular alterations before overt histological change. Spatial and single-cell profiling reveal heterogeneous trajectories and intermediate states, while functional models and multi-omics approaches have begun to identify therapeutic vulnerabilities distinct from both de novo EGFR-mutated SCLC and classical EGFR-mutated LUAD. Thus, lineage plasticity, whether manifested as histologic transformation or through more subtle epigenetic reprogramming, represents a formidable resistance mechanism in NSCLC. Defining its molecular basis and temporal dynamics will be essential for early detection, prognostication, and the development of tailored therapies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Lung NeoplasmsDrug Resistance, NeoplasmProtein Kinase InhibitorsCell Transformation, NeoplasticHumansErbB ReceptorsMutationAnimalsCell LineageEpigenesis, Genetic

Stichwörter der Autor:innen

EGFR-TKIacquired resistanceepigenetic reprogramminghistologic transformationlineage plasticitylung adenocarcinomalung cancertargeted therapytranscriptional reprogramming

Substanzen

ErbB ReceptorsProtein Kinase InhibitorsEGFR protein, human

Autor:innen und Institutionen

  • Genome Institute of Singapore (GIS), Agency for Science, Technology and Research (A*STAR), 60 Biopolis Street, Genome, Singapore 138672, Singapore.
  • Yong Loo Lin School of Medicine, National University of Singapore, 10 Medical Drive, Singapore 117597, Singapore.
  • Division of Medical Oncology, National Cancer Centre Singapore, Singapore 168583, Singapore.
  • Duke-NUS Medical School, National University of Singapore, Singapore 169857, Singapore.

ORCID-Profile: Li Yieng Eunice Lau, Aaron C Tan

Zitieren

APA

Lau, L. Y. E., Skanderup, A. J., & Tan, A. C. (2025). Lineage Plasticity and Histologic Transformation in EGFR-TKI Resistant Lung Cancer. International Journal of Molecular Sciences, 27(1), 445. https://doi.org/10.3390/ijms27010445

Vancouver

Lau LYE, Skanderup AJ, Tan AC. Lineage Plasticity and Histologic Transformation in EGFR-TKI Resistant Lung Cancer. International Journal of Molecular Sciences. 2025;27(1):445. doi:10.3390/ijms27010445

BibTeX
@article{Lau2025,
  author = {Lau, Li Yieng Eunice and Skanderup, Anders Jacobsen and Tan, Aaron C},
  title = {Lineage Plasticity and Histologic Transformation in EGFR-TKI Resistant Lung Cancer},
  journal = {International Journal of Molecular Sciences},
  year = {2025},
  volume = {27},
  number = {1},
  pages = {445},
  doi = {10.3390/ijms27010445}
}
Kostenlos starten →